Clinical Trial Detail

NCT ID NCT03344965
Title Olaparib In Metastatic Breast Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

breast cancer

Therapies

Olaparib

Age Groups: adult senior

Additional content available in CKB BOOST